Navigation Links
Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
Date:10/23/2007

Data Presented at Transcatheter Cardiovascular Therapeutics 2007 Scientific

Symposium

TEL AVIV, Israel and WASHINGTON DC, October 23 /PRNewswire-FirstCall/ -- TopSpin Medical (TASE: TOPMD) announced today that the 30-day results from the multicenter prospective study of the TopSpin Intravascular Magnetic Resonance Imaging System During Coronary Endovascular Catheterization (TOPIMAGE) demonstrated the safety and technical procedure success for the IntraVascular MRI (IVMRI) catheter in the coronary arteries. The study enrolled a total of 104 patients contributed from 10 centers in the US, Europe and Israel. Martin Leon, MD, of Columbia University Medical Center, New York, NY, and Co-Principal Investigator of the TOPIMAGE study, presented the study results at the Transcatheter Cardiovascular Therapeutics (TCT) 2007 Scientific Symposium in Washington DC.

"This study showed that the novel self-contained IVMRI system is feasible for use in the cardiac catheterization lab setting. We are pleased with the clinical results to-date, and we are enthusiastic to expand the clinical evaluation of the System," said William Wijns, MD, of Onze-Lieve-Vrouw Hospital, Aalst, Belgium, and Co-Principal Investigator of the Study.

The Company also announced that it has recently submitted a 510K application to the US FDA, which included the compiled TOPIMAGE results, as a required step toward obtaining marketing clearance for its IVMRI System in the US.

"Completion of the TOPIMAGE study and submission of 510K marketing application are major milestones for the Company and represent the culmination of several years of research and development. We believe that IVMRI will become a very beneficial diagnostic tool for early detection and guidance of treatment for high risk coronary plaques," said Yaron Tal, CEO of TopSpin Medical.

The TOPIMAGE study was designed to assess device safety and functional performance of the IVMRI Sys
'/>"/>

SOURCE TopSpin Medical Israel Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, has ... B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... amount per share equal to the quotient of (a) $3.00 ...
(Date:12/2/2009)... Corporation (Nasdaq: MATK ) announced today that it intends ... year 2009 on December 16, 2009, at approximately 4:00 p.m. ... ET Martek will conduct a conference call to discuss these ... the call live via webcast by visiting Martek,s web site ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... concept demonstration tires made with BioIsoprene technology, ... in the manufacture of synthetic rubber with renewable biomass, ... tire will be on display at a lounge in ... throughout December 21, while the other tire will make ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
... NV (Euronext,Brussels: THR), a biotechnology company focused on ... financial results for the seven month,period ending 30 ... funds to invest in its development pipeline and ... programs. Highlights - Successful placing of ...
... Aug. 24 AGA Medical Corporation ("AGA"),announced today ... Administration,(FDA) and European CE Mark approvals for the ... AMPLATZER Vascular Plug II expands the AGA family ... vessel and blood vessel,malformations in the peripheral vasculature. ...
... announced today the,release of two major upgrades to ... multilaser capability and the Beta release of a ... well beyond,conventional optical limitations. The Multilaser upgrade ... additional lasers including a 405nm (violet) laser and ...
Other Biology Technology:ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 2ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 3ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 4ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 5ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 6ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 7ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 8ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 9ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 10ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 11AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II 2Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System 2
(Date:12/4/2009)... activity in organs relevant for coronary artery disease (CAD), ... identified a module of genes that is important for ... plaque. The findings, which are to be published in ... targeting the migration of white blood cells in the ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
(Date:12/3/2009)... new information and adapt to changes in our daily environment, ... in the minute junctions where nerve cells communicate, according to ... study is published online this week in the journal ... PhD, associate professor of physiology and neuroscience at NYU School ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 1Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 2The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 1The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 2The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 3The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 4FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 1FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 2FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 3
... The way aquatic plants respond to plant disease ... land-based agriculture, say plant pathologists with The American ... III, Cornell University, Ithaca, NY, many aquatic plants ... "Through further study, plant pathologists may be able ...
... virus infiltrates human cells to cause encephalitis. Designated as ... Agenda, the virus exploits a protein essential to embryonic ... online edition of Nature reports the findings July 6. ... be used as a potential bioterrorism agent capable of ...
... blood disease, primarily affecting males, where the blood ... one in 6000 Australian males is born with ... with haemophilia rely on intravenous infusion of recombinant ... and her Harvard colleagues have made ground-breaking discoveries ...
Other Biology News:UCLA scientists reveal how Nipah virus infects cells 2Promising therapies for haemophilia & heart disease 2
... The x2 Dual-Binary Analytical System more ... binary LC and LC/MS. The fast analysis ... increased by up to 100% in tandem ... the multi-dimensional mode. Using backflush or heartcut ...
... weight of 16 kDa. Leptin is a protein ... [1,2]. Leptin is thought to play a key ... In the human, leptin levels are elevated with increasing ... relationship between serum leptin levels and several measures of ...
... random mutations to the gene supplied by a ... a vector of choice to obtain a library ... be set to a desired value within 1-20 ... Mutations can be restricted to a desired ...
Request Info...
Biology Products: